erlotinib hydrochloride has been researched along with pantoprazole in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (pantoprazole) | Trials (pantoprazole) | Recent Studies (post-2010) (pantoprazole) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 1,467 | 476 | 579 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | pantoprazole (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 1.5 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 2.8 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 7.75 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beijnen, JH; Fanggiday, JC; Lankheet, NA; Malingré, MM; Staaks, GH; Ter Heine, R; Van Der Westerlaken, MM | 1 |
1 other study(ies) available for erlotinib hydrochloride and pantoprazole
| Article | Year |
|---|---|
Erlotinib and pantoprazole: a relevant interaction or not?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Drug Interactions; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Quinazolines | 2010 |